Text Size
27 studies found for:    " February 21, 2007":" March 23, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" February 21, 2007":" March 23, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Computer Assisted Rx Education for HIV-Positives: CARE+
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention: Behavioral: CARE+
2 Completed
Has Results 		Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV) + ritonavir (/r);   Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV)
3 Completed
Has Results 		HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults
Conditions: Infection, Human Immunodeficiency Virus I;   HIV-1 Infection
Intervention: Drug: fosamprenavir/ritonavir
4 Unknown † Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users
Conditions: HIV Infections;   Crack Cocaine Use;   Risky Sexual Behavior
Interventions: Behavioral: Prevention Care Advocate;   Behavioral: Attention Control
5 Unknown † A Phase 2 Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Subjects
Condition: HIV Infections
Intervention: Drug: GS-9137
6 Completed Botswana TDF/FTC Oral HIV Prophylaxis Trial
Condition: HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg;   Drug: TDF-FTC placebo
7 Completed Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV
Condition: HIV Infections
Interventions: Drug: Tenofovir gel;   Drug: Placebo (Universal HEC placebo)
8 Completed Positive Choice: Prevention for Positive Health
Conditions: HIV Infections;   Sexual Risk Behavior;   Substance Use Risks
Intervention: Behavioral: Positive Choice
9 Completed HIV Prevention Among Substance Abusing SMI
Conditions: Mentally Ill Persons;   Substance Abuse;   HIV Infections
Intervention: Behavioral: PATH
10 Recruiting Enhancing Oral Health Care Use by HIV Positive Individuals
Conditions: Oral Hygiene;   HIV Infections;   Mouth Diseases
Intervention: Behavioral: Case-management linkage intervention
11 Completed Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes
Condition: HIV Infections
Intervention:
12 Completed Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults
Condition: HIV Infections
Interventions: Drug: TRIZIVIR;   Drug: Non-nucleoside reverse transcriptase inhibitor;   Drug: Boosted Protease Inhibitor
13 Completed Trial of Zinc and HIV Progression in Children
Condition: HIV Infections
Intervention: Dietary Supplement: Zinc
14 Completed
Has Results 		Pioglitazone to Treat Fatty Liver in People With HIV Infection
Conditions: HIV Infections;   Hepatic Steatosis;   Insulin Resistance
Intervention: Drug: Pioglitazone
15 Completed Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide
Condition: HIV Infections
Interventions: Drug: UC-781;   Drug: UC-781 placebo
16 Completed Safety Study of UC-781 Vaginal Microbicide
Condition: HIV Infections
Interventions: Drug: Placebo gel;   Drug: UC 781
17 Completed Effect of Atazanavir on Endothelial Function in HIV-Infected Patients
Conditions: HIV Infections;   Dyslipidemia
Intervention: Drug: ATAZANAVIR
18 Completed Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients
Condition: HIV Infection
Intervention:
19 Terminated
Has Results 		Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir
20 Terminated
Has Results 		MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)
Condition: HIV Infection
Interventions: Drug: MK0518 (raltegravir);   Drug: Comparator: KALETRA™ (lopinavir (+) ritonavir );   Drug: Comparator: placebo
To Top

Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results
† Indicates status has not been verified in more than two years